scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1005056275 |
P356 | DOI | 10.1186/1465-9921-13-35 |
P932 | PMC publication ID | 3351013 |
P698 | PubMed publication ID | 22513083 |
P5875 | ResearchGate publication ID | 224707708 |
P50 | author | Zhong Nanshan | Q9096750 |
Kian Fan Chung | Q43222898 | ||
P2093 | author name string | Qingling Zhang | |
Andrew Menzies-Gow | |||
Christopher K Hui | |||
Rowland Illing | |||
Khalid Alshafi | |||
Denis Carr | |||
Kate Downey | |||
Martin Stearn | |||
P2860 | cites work | Disordered microbial communities in asthmatic airways | Q21562589 |
Increased risk of serious pneumococcal disease in patients with asthma | Q33612894 | ||
Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respira | Q33691584 | ||
Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma | Q33782854 | ||
Airway remodeling measured by multidetector CT is increased in severe asthma and correlates with pathology | Q33810699 | ||
Asthma. From bronchoconstriction to airways inflammation and remodeling | Q33915771 | ||
Airway wall thickness in patients with near fatal asthma and control groups: assessment with high resolution computed tomographic scanning | Q35532362 | ||
Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors | Q35534781 | ||
Correlation between the bronchial subepithelial layer and whole airway wall thickness in patients with asthma | Q35535009 | ||
High resolution computed tomographic assessment of airway wall thickness in chronic asthma: reproducibility and relationship with lung function and severity | Q35535050 | ||
Bronchial hyperresponsiveness and bacterial respiratory infections | Q36648730 | ||
Alveolar macrophage phagocytosis is impaired in children with poorly controlled asthma | Q36741283 | ||
Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype | Q37315359 | ||
Infection in the pathogenesis and course of chronic obstructive pulmonary disease | Q37336494 | ||
Atypical pathogen infection in adults with acute exacerbation of bronchial asthma | Q37870844 | ||
LPS-induced cytokine production in human monocytes and macrophages | Q37964759 | ||
Simple method for quantifying viable bacterial numbers in sputum | Q39652885 | ||
Airway epithelial cells regulate the functional phenotype of locally differentiating dendritic cells: implications for the pathogenesis of infectious and allergic airway disease. | Q39901620 | ||
Defective apoptotic cell phagocytosis attenuates prostaglandin E2 and 15-hydroxyeicosatetraenoic acid in severe asthma alveolar macrophages | Q40393862 | ||
Th2 cytokines associated with chronic rhinosinusitis with polyps down-regulate the antimicrobial immune function of human sinonasal epithelial cells | Q42732599 | ||
Potentially pathogenic bacteria cultured from the sputum of stable asthmatics are associated with increased 8-isoprostane and airway neutrophilia | Q43239609 | ||
Systematic assessment of difficult-to-treat asthma | Q44600699 | ||
Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD. | Q47397957 | ||
Parameters associated with persistent airflow obstruction in chronic severe asthma | Q47946784 | ||
Asthma as a risk factor for invasive pneumococcal disease. | Q50761639 | ||
Sex differences in emphysema and airway disease in smokers. | Q51625549 | ||
Immune responses of airway neutrophils are impaired in asthma. | Q54458296 | ||
Suppression of the immune system by oral glucocorticoid therapy in bronchial asthma | Q61959867 | ||
Chest radiography and high resolution computed tomography of the lungs in asthma | Q67567759 | ||
Symbols, abbreviations and units. Working Party Standardization of Lung Function Tests, European Community for Steel and Coal | Q70730312 | ||
Computed tomography of the lungs in asthma: influence of disease severity and etiology | Q70838878 | ||
Human airway narrowing measured using high resolution computed tomography | Q71767484 | ||
Airway wall thickness in asthma assessed by computed tomography. Relation to clinical indices | Q73071814 | ||
Neutrophilic inflammation in severe persistent asthma | Q73168418 | ||
Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society | Q73286389 | ||
Bronchial inflammation and colonization in patients with clinically stable bronchiectasis | Q77220384 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | asthma | Q35869 |
sputum | Q259346 | ||
P304 | page(s) | 35 | |
P577 | publication date | 2012-04-18 | |
P1433 | published in | Respiratory Research | Q7315904 |
P1476 | title | Bacteria in sputum of stable severe asthma and increased airway wall thickness | |
P478 | volume | 13 |
Q34472976 | 25-Hydroxyvitamin D3-deficiency enhances oxidative stress and corticosteroid resistance in severe asthma exacerbation |
Q35989768 | Airway Microbiota in Severe Asthma and Relationship to Asthma Severity and Phenotypes |
Q44052633 | Airway exposure to staphylococcal enterotoxin A potentiates allergen-induced bone marrow eosinophilia and trafficking to peripheral blood and airways. |
Q38528048 | Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies |
Q38078465 | Bacterial superinfection following lung inflammatory disorders. |
Q38786693 | Clinical approaches towards asthma and chronic obstructive pulmonary disease based on the heterogeneity of disease pathogenesis |
Q38209438 | Defining phenotypes in asthma: a step towards personalized medicine |
Q45844503 | Effect of TRPV1 channel on the proliferation and apoptosis in asthmatic rat airway smooth muscle cells |
Q91605371 | Elevated serum Activin A in chronic obstructive pulmonary disease with skeletal muscle wasting |
Q41672961 | Eotaxin-3 (CCL26) exerts innate host defense activities that are modulated by mast cell proteases. |
Q36040504 | High IFN-γ and low SLPI mark severe asthma in mice and humans |
Q28657369 | How variability in clinical phenotypes should guide research into disease mechanisms in asthma |
Q33864335 | Impaired macrophage phagocytosis of bacteria in severe asthma. |
Q30364236 | Infection in severe asthma exacerbations and critical asthma syndrome. |
Q35816380 | Involvement of Toll-like receptor 2 and epidermal growth factor receptor signaling in epithelial expression of airway remodeling factors |
Q38645834 | Neutrophilic Inflammation in Asthma and Association with Disease Severity |
Q38181697 | New treatments for severe treatment-resistant asthma: targeting the right patient |
Q30252507 | Pathogenic CD4+ T cells in patients with asthma |
Q39148802 | Phenotype-Driven Therapeutics in Severe Asthma |
Q47704287 | Potential Role of the Lung Microbiome in Shaping Asthma Phenotypes |
Q35068408 | Procalcitonin guided antibiotic therapy of acute exacerbations of asthma: a randomized controlled trial |
Q47788593 | Profile of the ProAxsis active neutrophil elastase immunoassay for precision medicine in chronic respiratory disease |
Q34211965 | Systemic and pulmonary inflammation is independent of skeletal muscle changes in patients with chronic obstructive pulmonary disease. |
Q35594963 | The changing face of asthma and its relation with microbes |
Q40307081 | The interactions between microorganisms and the small airways. A paediatric focus |
Q28086865 | The lung microbiome in 2015: a window on chronic lung diseases |
Search more.